Product Name

Ceftazidime anhydrous Specification

The Ceftazidime anhydrous with CAS registry number of 72558-82-8 is also known as Ceftazidime anhydrous. The IUPAC name is (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. It belongs to product categories of Chiral Reagents; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds. Its EINECS registry number is 276-715-9. In addition, the formula is C22H22N6O7S2 and the molecular weight is 546.58.

Physical properties about Ceftazidime anhydrous are: (1)# of Rule of 5 Violations: 3; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 1; (5)ACD/KOC (pH 7.4): 1; (6)#H bond acceptors: 13; (7)#H bond donors: 5; (8)#Freely Rotating Bonds: 9; (9)Polar Surface Area: 202.19Å2.

Preparation of Ceftazidime anhydrous: it is prepared by reaction of cefotaxime pyridine. Firstly, cefotaxime pyridine reacts with trimethyl silicon chloride and phosphorus pentachloride to get amorphous solid. Dealing with the solid by acetonitrile containing hydrochloric acid. Secondly, the compound reacts with (z)-2-(2-tert-butoxy carbonyl C-2-oxygen Nokia amino)-2-(2-triphenylmethyl-amino thiazol-4-yl) acetyl chloride with solvent dichloromethane. Thirdly, add mixture of dimethylformamide, formic acid and hydrochloric acid after washing and steaming. At last, add acetone or methanol after removing sediment. Compound is dissolved in water and the precipitate is the Ceftazidime.

Ceftazidime is prepared by reaction of cefotaxime pyridine.

Uses of Ceftazidime anhydrous: it is mainly used as clinical medicine for respiratory system, urinary system, soft tissue infections caused by susceptible. Ceftazidime anhydrous is used as third-generation broad-spectrum cephalosporin.

When you are using Ceftazidime anhydrous, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. It is harmful by inhalation, in contact with skin and if swallowed. During using it, wear suitable protective clothing. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES:O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=NOC(C(=O)O)(C)C)c3nc(sc3)N)C[n+]4ccccc4)C([O-])=O;
(2)Std. InChI:InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/t14-,18-/m1/s1;
(3)Std. InChIKey:ORFOPKXBNMVMKC-RDTXWAMCSA-N.

The toxicity data of Ceftazidime anhydrous is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intramuscular > 4gm/kg (4000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Chemotherapy Vol. 31(Suppl,
mouse LD50 intraperitoneal 11gm/kg (11000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
mouse LD50 intravenous 6300mg/kg (6300mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
mouse LD50 oral > 20gm/kg (20000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Chemotherapy Vol. 31(Suppl,
mouse LD50 subcutaneous 20gm/kg (20000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
rabbit LD50 intramuscular 2gm/kg (2000mg/kg)   Chemotherapy Vol. 31(Suppl,
rabbit LD50 intravenous > 2gm/kg (2000mg/kg) BEHAVIORAL: FOOD INTAKE (ANIMAL)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Chemotherapy Vol. 31(Suppl,
rat LD50 intramuscular > 4gm/kg (4000mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
rat LD50 intraperitoneal 10gm/kg (10000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
rat LD50 intravenous 5800mg/kg (5800mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
rat LD50 oral > 20gm/kg (20000mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,
rat LD50 subcutaneous 20gm/kg (20000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Chemotherapy Vol. 31(Suppl,

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View